
A Medicine Company | Eli Lilly and Company
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Eli Lilly and Company - Wikipedia
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries.
Lilly to acquire Ventyx Biosciences to advance oral therapies …
2 days ago · "We believe that Lilly is an ideal strategic partner, with unparalleled resources, a passion for innovative oral drugs and a commitment to advance novel therapies that fill a vast …
Eli Lilly and Company - Encyclopedia Britannica
Eli Lilly and Company is one of the world’s largest research-based pharmaceutical and biomedical companies,...
Eli Lilly & Co - Company Profile and News - Bloomberg Markets
Jan 2, 2026 · Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world.
Lilly’s Path to $94B in Revenue Rests on Oral Obesity ... - BioSpace
4 days ago · Eli Lilly is on a path to achieving $94.3 billion in annual revenue by 2027, with 2026 serving as a critical year that will define the Big Pharma’s future. Leerink Partners predicted …
Exclusive | Eli Lilly Nears Deal for Biotech Ventyx - WSJ
Eli Lilly LLY0.64%increase; green up pointing triangle is in advanced talks to acquire Ventyx Biosciences VTYX-0.14%decrease; red down pointing triangle for around $1 billion, according …
Eli Lilly cuts cash prices of Zepbound weight loss drug vials
Dec 1, 2025 · Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec. 1, …
Lilly returns to Nimbus in $1.3B deal to create oral obesity med
3 days ago · Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies.
Indiana sues Eli Lilly over insulin prices | wthr.com
4 days ago · INDIANAPOLIS — The state of Indiana is suing local pharmaceutical giant Eli Lilly and Company over insulin prices. Indiana joins a list of states accusing Lilly of inflating drug …